Christine Fox, EVP, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 7,924 shares at $31.67 ($251K) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Scheduled sale ($251k) by EVP, U.S. Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2025-11-24 | $1.4M | — | Filing → |
| TEVA | SELL | 2025-11-18 | $753K | — | Filing → |
| TEVA | SELL | 2025-03-06 | $161K | — | Filing → |